The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of the third and subsequent lines of chemotherapy in the cure rate of patients with high-risk gestational trophoblastic neoplasia (HR-GTN).
Gustavo Jankilevich
No relevant relationships to disclose
Maria Ines Bianconi
No relevant relationships to disclose
Silvina Otero
No relevant relationships to disclose
Lucia Alvarez
No relevant relationships to disclose
Claudio Storino
No relevant relationships to disclose